Cairns Tina M, Shaner Marie S, Zuo Yi, Ponce-de-Leon Manuel, Baribaud Isabelle, Eisenberg Roselyn J, Cohen Gary H, Whitbeck J Charles
Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
J Virol. 2006 Mar;80(6):2596-608. doi: 10.1128/JVI.80.6.2596-2608.2006.
The gH/gL complex plays an essential role in virus entry and cell-cell spread of herpes simplex virus (HSV). Very few immunologic reagents were previously available to either identify important functional regions or gain information about structural features of this complex. Therefore, we generated and characterized a panel of 31 monoclonal antibodies (MAbs) against HSV type 2 (HSV-2) gH/gL. Fourteen MAbs bound to a conformation-dependent epitope of the gH2/gL2 complex, and all blocked virus spread. The other 17 MAbs recognized linear epitopes of gH (12) or gL (5). Interestingly, two of the gL MAbs and six of the gH MAbs were type common. Overlapping synthetic peptides were used to map MAbs against linear epitopes. These data, along with results of competition analyses and functional assays, assigned the MAbs to groups representing eight distinct antigenic sites on gH (I to VIII) and three sites on gL (A, B, and C). Of most importance, the MAbs with biological activity mapped either to site I of gH2 (amino acids 19 to 38) or to sites B and C of gL2 (residues 191 to 210). Thus, these MAbs constitute a novel set of reagents, including the first such reagents against gH2 and gL2 as well as some that recognize both serotypes of each protein. Several recognize important functional domains of gH2, gL2, or the complex. We suggest a common grouping scheme for all of the known MAbs against gH/gL of both HSV-1 and HSV-2.
gH/gL复合物在单纯疱疹病毒(HSV)的病毒进入和细胞间传播中起着至关重要的作用。以前几乎没有免疫试剂可用于识别该复合物的重要功能区域或获取其结构特征的信息。因此,我们制备并鉴定了一组针对2型单纯疱疹病毒(HSV-2)gH/gL的31种单克隆抗体(MAb)。14种MAb与gH2/gL2复合物的构象依赖性表位结合,并且全部阻断病毒传播。另外17种MAb识别gH(12种)或gL(5种)的线性表位。有趣的是,2种gL MAb和6种gH MAb是两型共有的。重叠合成肽用于绘制针对线性表位的MAb图谱。这些数据以及竞争分析和功能测定的结果,将MAb分为代表gH上八个不同抗原位点(I至VIII)和gL上三个位点(A、B和C)的组。最重要的是,具有生物学活性的MAb要么定位于gH2的位点I(氨基酸19至38),要么定位于gL2的位点B和C(残基191至210)。因此,这些MAb构成了一组新型试剂,包括首批针对gH2和gL2的此类试剂以及一些识别每种蛋白质两种血清型的试剂。几种试剂识别gH2、gL2或复合物的重要功能域。我们提出了一种针对所有已知的针对HSV-1和HSV-2的gH/gL的MAb的通用分组方案。